New Search

If you are not happy with the results below please do another search

36 search results for:

21

Ways that generative AI can facilitate and accelerate work

/0 Comments/in
Ways that generative AI can facilitate and accelerate work The 502 page report by Stanford that came out earlier raises several points for consideration by knowledge workers. As the different generative ai models adapt and learn, they grow better at supporting and substituting tasks typically done by knowledge workers. While gaps persist, the question arising [...]
22

Sharing learnings: Unleashing the power of private generative AI in Medical Affairs

/0 Comments/in
Sharing learnings: Unleashing the power of private generative AI in Medical Affairs Today's blog post provides key learnings from the linkedin webinar held on May 28, 2024, offering a compelling overview into current applications of generative AI in Medical Affairs leveraging private or bespoke generative AI. Whether you're seeking to streamline operations, enhance accuracy, or [...]
23

Exploring JCA Timelines: Opportunities and Challenges

/0 Comments/in
Exploring JCA Timelines: Opportunities and Challenges for Pharma and Biotech In the evolving landscape of EU healthcare, the introduction of Joint Clinical Assessments (JCA) as part of the new Health Technology Assessment (HTA) regulations signifies a pivotal shift. These assessments are redefining Pharma and Biotech companies' approach to product evaluation and approval, presenting both significant [...]
24

Swiss Rare Disease Day 2024: Insights from the ProRaris Event

/0 Comments/in
Swiss Rare Disease Day 2024: Insights from the ProRaris Event at the Inselspital Bern On March 2nd, 2024, the event "Internationaler Tag der seltenen Krankeiten in der Schweiz" took place at the Auditorium Ettore Rossi, Inselspital Bern, to commemorate the 14th International Rare Disease Day in Switzerland. Organized by ProRaris, the symposium gathered around 150 [...]
25

Preparing for EU Joint Clinical Assessment 2025

/0 Comments/in
Preparing for EU Joint Clinical Assessment 2025: Leveraging Gen AI Technology to Navigate the New Era in Health Technology Assessment   As we edge closer to 2025, the pharmaceutical landscape in Europe is poised for a transformative change with the implementation of the new EU Health Technology Assessment (HTA) regulations. This pivotal move, aimed at harmonizing [...]
26

Pharma WhatsApp communications with physicians

/0 Comments/in
Solutions WhatsApp Business API for Pharma & Physician Communications While pharmaceutical organizations and the healthcare sector have been becoming increasingly more digitalized, it was the COVID-19 pandemic that accelerated the need for much faster adoption and agility, including digital communication channels between pharma organizations and healthcare professionals. The healthcare sector, together with hospitals, physicians and [...]
27

Insights from Generative AI Implementations: 4 Focus Areas

/0 Comments/in
Solutions 9 Months In: Insights from Generative AI Implementations in Pharma & Biotech - Our 4 Focus Areas In an age of rapid technological breakthroughs, the usage of artificial intelligence has progressed beyond mere buzzwords to become an essential component of company operations. A subclass of AI known as generative AI has enormous promise, allowing [...]
28

Bespoke ChatGPT for compliant, impactful patient & healthcare professionals engagement

/0 Comments/in
Solutions Bespoke ChatGPT for compliant, impactful patient & healthcare professionals engagement Contact us now for a live-demo In today's rapidly evolving healthcare landscape, effective communication between pharmaceutical companies, patients, healthcare professionals (HCPs), and nurses is paramount. To bridge the gap and deliver exceptional customer experiences, a groundbreaking solution has emerged: Custom ChatGPT using Pharma-owned & [...]
29

Rapid scaling & agile organization to deliver results

/0 Comments/in

Whether the fast launch of a pharma product, a rapid business assessment, tapping into a network of experts in a specific therapy area, engaging a new medical target audience or developing and running a promotional campaign – we have the expertise and capabilities to support you and create solutions that work. On time, within your budget and delivering results.

30

International market access & pricing

/0 Comments/in

Securing broad access to a novel therapy is essential for launch success. Building on deep therapy area insights, we facilitated early and constructive engagement with payers in key countries, allowing to identify the key evidence needs in time. Leveraging our broad international network, we brought the relevant players to the table, allowing the company to make informed decisions in time.